Literature DB >> 30528250

Different frequencies of memory B-cells induced by tetanus, botulinum, and heat-labile toxin binding domains.

Ehsan Rezaie1, Hekmat Nekoie2, Ali Miri3, Gholamreza Oulad4, Ali Ahmadi1, Mojtaba Saadati2, Mahmood Bozorgmehr5, Marzieh Ebrahimi6, Jafar Salimian7.   

Abstract

Along with robust immunogenicity, an ideal vaccine candidate should be able to produce a long lasting protection. In this regard, the frequency of memory B-cells is possibly an important factor in memory B-cell persistency and duration of immunological memory. On this basis, binding domains of tetanus toxin (HcT), botulinum type A1 toxin (HcA), and heat-labile toxin (LTB) were selected as antigen models that induced long-term, midterm and short-term immune memory, respectively. In the present study, the frequency of total memory B-cells after immunization with HcT, HcA and LTB antigens after 90 and 180 days, and also after one booster, in 190 days, was evaluated. The results showed a significant correlation between frequency of total memory B-cells and duration of humoral immunity. Compared to other antigens, the HcT antibody titers and HcT total memory B-cell populations were greater and persistent even after 6 months. At 6 months after the final immunization, all HcT- and HcA-immunized mice survived against tetanus and botulinum toxins, and also LT toxin binding to GM1 ganglioside was blocked in LTB-immunized mice. We conclude the frequency of memory B-cells and their duration are likely a key factor for vaccine memory duration.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Botulinum toxin; Frequency; Heat-labile toxin; Memory B-cell; Tetanus toxin; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 30528250     DOI: 10.1016/j.micpath.2018.12.003

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

1.  In silico analysis of STX2a-PE15-P4A8 chimeric protein as a novel immunotoxin for cancer therapy.

Authors:  Maryam Keshtvarz; Jafar Salimian; Jafar Amani; Masoumeh Douraghi; Ehsan Rezaie
Journal:  In Silico Pharmacol       Date:  2021-02-10

2.  Engineering of Cytolethal Distending Toxin B by Its Reducing Immunogenicity and Maintaining Stability as a New Drug Candidate for Tumor Therapy; an In Silico Study.

Authors:  Maryam Keshtvarz; Mahdieh Mahboobi; Marek Kieliszek; Antoni Miecznikowski; Hamid Sedighian; Milad Rezaei; Mohammad Ali Haghighi; Zahra Zareh; Ehsan Rezaei
Journal:  Toxins (Basel)       Date:  2021-11-05       Impact factor: 4.546

Review 3.  Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect.

Authors:  Mohammad Heiat; Hamid Hashemi Yeganeh; Seyed Moayed Alavian; Ehsan Rezaie
Journal:  Toxins (Basel)       Date:  2021-10-11       Impact factor: 4.546

4.  DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study.

Authors:  Hamid Hashemi Yeganeh; Mohammad Heiat; Marek Kieliszek; Seyed Moayed Alavian; Ehsan Rezaie
Journal:  Toxins (Basel)       Date:  2021-10-22       Impact factor: 4.546

5.  Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine.

Authors:  Majdedin Ghalavand; Mojtaba Saadati; Jafar Salimian; Ebrahim Abbasi; Ghader Hosseinzadeh; Hadi Esmaeili Gouvarchin Ghaleh; Ali Ahmadi
Journal:  Clin Exp Vaccine Res       Date:  2021-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.